Nellmarie Bodenstein, GP – Clinical use of LDN in South Africa – 2022 Conference (LDN, low dose naltrexone)
Nellmarie Bodenstein, GP – Clinical use of LDN in South Africa – 2022 Conference (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – LDN and Thyroid – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – LDN and Thyroid – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – Major Depressive Disorder – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – Major Depressive Disorder – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Edyta Biernat-Kałuża, MD, PhD – Pain – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Edyta Biernat-Kałuża, MD, PhD – Pain – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Yusuf Saleeby, MD – IBD – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Yusuf Saleeby, MD – IBD – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Kimberly Hansen, RPh – History of LDN – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Kimberly Hansen, RPh – History of LDN – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Akbar Khan, MD – Cancer – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Akbar Khan, MD – Cancer – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Kim Hansen, RPh – Closing – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Kim Hansen, RPh – Closing – 2020 Conference; Bahamas (LDN, low dose naltrexone)